<DOC>
	<DOCNO>NCT02502786</DOCNO>
	<brief_summary>The purpose study find effect antibody call Humanized 3F8 ( Hu3F8 ) drug call GM-CSF patient whether keep patient remission longer and/or prevent recurrence disease .</brief_summary>
	<brief_title>Humanized Monoclonal Antibody 3F8 ( Hu3F8 ) With Granulocyte-Macrophage Colony Stimulating Factor ( GM-CSF ) Treatment Recurrent Osteosarcoma</brief_title>
	<detailed_description />
	<mesh_term>Osteosarcoma</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>Patients must recurrent OS OS must verify histopathology review site 's Department Pathology . ( Patients register MSKCC must pathology confirm MSKCC Department Pathology . ) Patients must ≥2nd complete remission indicate appropriate radiologic evaluation time study entry . Patients must older 1 year age less equal 40 year age . Prior therapy : ≥3 week elapse since last cytotoxic therapy , immunotherapy radiation therapy . More one week elapse since major surgery . Adequate hematopoietic function define : Absolute neutrophil count ≥ 500/ul Absolute lymphocyte count ≥ 500/ul Platelet count ≥ 50,000/ul ( transfusion independent ) Adequate hepatic function define : Total bilirubin ≤ 1.5 time upper limit normal ( exception make patient Gilbert 's syndrome may consider eligible total bilirubin ≤ 3 time upper limit normal ) . AST ≤ 3 time upper limit normal ALT ≤ 3 time upper limit normal Adequate renal function define serum creatinine ≤ 1.5 time upper limit normal Adequate cardiac function define shorten fraction ≥ 28 % ejection fraction ≥ 50 % Adequate performance status define ECOG score ≤ 2 Karnofsky/Lansky score ≥ 50 % Prior treatment antiGD2 antibody allow ( prior treatment hu3F8 NOT allow ) , HAHA antibody titer must ≤1300 Elisa units/mL Women childbearing potential must willing practice effective method birth control treatment Signed informed consent indicate awareness investigational nature program Patients OS first complete remission . Presence overt metastatic disease site . Active lifethreatening infection . Pregnant woman woman breastfeed . Inability comply protocol requirement .</criteria>
	<gender>All</gender>
	<minimum_age>13 Months</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Humanized Monoclonal Antibody 3F8 ( Hu3F8 )</keyword>
	<keyword>Granulocyte-Macrophage Colony Stimulating Factor ( GM-CSF )</keyword>
	<keyword>15-096</keyword>
</DOC>